REBECCA SHUKHMAN: Open Payments
NPI 1902335433 · SKOKIE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,030 in 138 payments from 17 companies in 2025. Trend: 2023 $5,874 · 2024 $2,019 · 2025 $3,030
Food & beverage: $3,022Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $548 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $466 |
| Supernus Pharmaceuticals, Inc. | 16 | $288 |
| Tris Pharma Inc | 8 | $267 |
| Otsuka America Pharmaceutical, Inc. | 9 | $232 |
| Corium, LLC | 11 | $188 |
| Axsome Therapeutics, Inc. | 9 | $159 |
| Alkermes, Inc. | 4 | $142 |
| Lundbeck LLC | 9 | $142 |
| Neos Therapeutics, LP | 3 | $139 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Qelbree, Dyanavel XR, Azstarys, Adzenys XR-ODT, LYBALVI.
Industry payments across IL — which companies pay providers there.
